These results suggest that in prostate adenocarcinoma ERG expression co-occurs with PACE4-altCT despite the apparent lack of causality between the two events knowing that ERG expression tends to slightly reduce PACE4-altCT levels in cells (Fig. 1). Here, ERG is linked to prostate adenocarcinoma.